AAAAAA

   
Results: 1-3 |
Results: 3

Authors: Byrd, JC Murphy, T Howard, RS Lucas, MS Goodrich, A Park, K Pearson, M Waselenko, JK Ling, G Grever, MR Grillo-Lopez, AJ Rosenberg, J Kunkel, L Flinn, IW
Citation: Jc. Byrd et al., Rituximab using a thrice weekly dosing schedule in B-Cell chronic lymphocytic leukemia and small lymphocytic lymphoma demonstrates clinical activity and acceptable toxicity, J CL ONCOL, 19(8), 2001, pp. 2153-2164

Authors: Flinn, IW O'Donnell, PV Goodrich, A Vogelsang, G Abrams, R Noga, S Marcellus, D Borowitz, M Jones, R Ambinder, RF
Citation: Iw. Flinn et al., Immunotherapy with rituximab during peripheral blood stem cell transplantation for non-Hodgkin's lymphoma, BIOL BLOOD, 6(6), 2000, pp. 628-632

Authors: Byrd, JC Grever, MR Waselenko, JK Willis, CR Park, K Goodrich, A Lucas, MA Shinn, C Flinn, IW
Citation: Jc. Byrd et al., Theophylline, pentostatin (Nipent), and chlorambucil: A dose-escalation study targeting intrinsic biologic resistance mechanisms in patients with relapsed lymphoproliferative disorders, SEMIN ONCOL, 27(2), 2000, pp. 37-40
Risultati: 1-3 |